AbbVie said it will buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major depression, a sign that ...

The FDA has begun publishing reports of adverse events concerning drugs and biological products on a daily basis ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...

Good morning. For all our talk about potato chips in this newsletter, nobody has ever attempted to give a STAT reporter a wad ...

Amid demand for retraction, a leading medical journal is reviewing a discredited study published in 2001 that touted the ...

Rather than thinking in terms of single targets or isolated therapeutic classes, we now have the opportunity and imperative ...

After an M.D./Ph.D. started using testosterone, he felt incredible — until he realized his lab results showed something alarming.

Join our Sept 16 virtual event to explore fundamental gaps in asthma care and actionable strategies for improvement through ...

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...

He was 21 when he programmed MyChart — now he’s the president of Epic. STAT sat down with Sumit Rana for a wide-ranging ...

A major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, the FDA found in a ...

Employers are about to spend a lot more on health insurance next year as they shoulder higher costs driven by GLP-1 drugs, ...